Literature DB >> 8792478

Intrathecal production of neopterin and beta 2 microglobulin in tick-borne encephalitis (TBE) compared to meningoencephalitis of other etiology.

G Günther1, M Haglund, L Lindquist, B Sköldenberg, M Forsgren.   

Abstract

To study the pathophysiology of tick-borne encephalitis (TBE), the kinetics of neopterin and beta 2 microglobulin (beta 2M) production were measured in sequential, cerebrospinal fluid (CSF) and serum samples in 133 patients with aseptic meningoencephalitis (TBE, n = 72; non-TBE, n = 61). Intrathecal production of neopterin was demonstrable in all patients. Neopterin levels in CSF were elevated already at day 2: geometric mean value in TBE 36 nmol/l (range 1-253), in the non-TBE group 29 nmol/l (0.2-96). At day 9 and week 6 the neopterin level was significantly higher in TBE (86 (19-725) and 17 (4-122) nmol/l) than in non-TBE (28 (5-109) and 3 (0.2-58) nmol/l) (p < 0.001). After 1 year CSF levels were within the normal range. The beta 2M response in CSF followed the pattern of neopterin. The intensity and duration of neopterin and beta 2M was not correlated to the clinical course. Neopterin seems to be a more sensitive indicator of intrathecal T-cell response and inflammatory reaction than beta 2M. The results indicate that a long-lasting strong inflammatory reaction is of pathophysiological significance in TBE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8792478     DOI: 10.3109/00365549609049063

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  7 in total

1.  Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults.

Authors:  B Sköldenberg; E Aurelius; A Hjalmarsson; F Sabri; M Forsgren; B Andersson; A Linde; O Strannegård; M Studahl; L Hagberg; L Rosengren
Journal:  J Neurol       Date:  2005-10-17       Impact factor: 4.849

2.  Tick-bone encephalitis in Sweden in relation to aseptic meningo-encephalitis of other etiology: a prospective study of clinical course and outcome.

Authors:  G Günther; M Haglund; L Lindquist; M Forsgren; B Sköldenberg
Journal:  J Neurol       Date:  1997-04       Impact factor: 4.849

3.  May early intervention with high dose intravenous immunoglobulin pose a potentially successful treatment for severe cases of tick-borne encephalitis?

Authors:  Daniel Růžek; Gerhard Dobler; Hans Helmut Niller
Journal:  BMC Infect Dis       Date:  2013-07-03       Impact factor: 3.090

4.  The expression of the chemokine receptor CCR5 in tick-borne encephalitis.

Authors:  Sambor Grygorczuk; Joanna Osada; Miłosz Parczewski; Anna Moniuszko; Renata Świerzbińska; Maciej Kondrusik; Piotr Czupryna; Justyna Dunaj; Milena Dąbrowska; Sławomir Pancewicz
Journal:  J Neuroinflammation       Date:  2016-02-22       Impact factor: 8.322

5.  Intrathecal complement activation by the classical pathway in tick-borne encephalitis.

Authors:  Malin Veje; Marie Studahl; Tomas Bergström
Journal:  J Neurovirol       Date:  2019-03-08       Impact factor: 2.643

6.  Tick-borne encephalitis is associated with low levels of interleukin-10 in cerebrospinal fluid.

Authors:  Göran Günther; Mats Haglund; Lars Lindquist; Marianne Forsgren; Jan Andersson; Birger Andersson; Birgit Sköldenberg
Journal:  Infect Ecol Epidemiol       Date:  2011-02-11

Review 7.  Pathogenesis of flavivirus encephalitis.

Authors:  Thomas J Chambers; Michael S Diamond
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.